Table of Content 1 Industry Overview 1.1 Drugs for Non-small Cell Lung Cancer Industry 1.1.1 Overview 1.1.2 Products of Major Companies 1.2 Market Segment 1.2.1 Industry Chain 1.2.2 Consumer Distribution 1.3 Price & Cost Overview 2 Drugs for Non-small Cell Lung Cancer Market by Type 2.1 By Type 2.1.1 Radiofrequency Ablation (RFA)  2.1.2 Radiation Therapy  2.1.3 Chemotherapy  2.1.4 Targeted Therapies  2.1.5 Immunotherapy 2.2 Market Size by Type 2.3 Market Forecast by Type 3 Global Market Demand 3.1 Segment Overview 3.1.1 Hospital  3.1.2 Clinic  3.1.3 Others 3.2 Market Size by Demand 3.3 Market Forecast by Demand 4 Major Region Market 4.1 Global Market Overview 4.1.1 Market Size & Growth 4.1.2 Market Forecast 4.2 Major Region 4.2.1 Market Size & Growth 4.2.2 Market Forecast 5 Major Companies List 5.1 Bristol-Myers Squibb  (Company Profile, Sales Data etc.) 5.2 GlaxoSmithKline  (Company Profile, Sales Data etc.) 5.3 Menarini  (Company Profile, Sales Data etc.) 5.4 Sanofi  (Company Profile, Sales Data etc.) 5.5 Ziopharm Oncology  (Company Profile, Sales Data etc.) 5.6 Alchemia  (Company Profile, Sales Data etc.) 5.7 Amgen  (Company Profile, Sales Data etc.) 5.8 Apotex  (Company Profile, Sales Data etc.) 5.9 BioMarin Pharmaceutical  (Company Profile, Sales Data etc.) 5.10 CellAct Pharma  (Company Profile, Sales Data etc.) 5.11 Cerulean Pharma  (Company Profile, Sales Data etc.) 5.12 Cipla  (Company Profile, Sales Data etc.) 5.13 Cornerstone Pharmaceuticals  (Company Profile, Sales Data etc.) 5.14 Curis  (Company Profile, Sales Data etc.) 5.15 CytRx  (Company Profile, Sales Data etc.) 5.16 Eli Lilly  (Company Profile, Sales Data etc.) 5.17 Exelixis  (Company Profile, Sales Data etc.) 5.18 Fresenius Kabi  (Company Profile, Sales Data etc.) 5.19 Genentech  (Company Profile, Sales Data etc.) 5.20 Hikma Pharmaceuticals  (Company Profile, Sales Data etc.) 5.21 Hospira  (Company Profile, Sales Data etc.) 5.22 Intas Pharmaceuticals  (Company Profile, Sales Data etc.) 5.23 Karyopharm Therapeutics  (Company Profile, Sales Data etc.) 5.24 Kyowa Hakko Kirin  (Company Profile, Sales Data etc.) 5.25 Ligand Pharmaceuticals (Company Profile, Sales Data etc.) 6 Conclusion

List of Table Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2019, by Type, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2019, by Type, in Volume Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, by Type, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, by Type, in Volume Table Global Drugs for Non-small Cell Lung Cancer Demand 2016-2019, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Demand 2016-2019, in Volume Table Global Drugs for Non-small Cell Lung Cancer Demand Forecast 2020-2026, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Demand Forecast 2020-2026, in Volume Table Global Drugs for Non-small Cell Lung Cancer Market Size & Growth 2016-2019, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market Size & Growth 2016-2019, in Volume Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, in Volume Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2019, by Region, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market 2016-2019, by Region, in Volume Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, by Region, in USD Million Table Global Drugs for Non-small Cell Lung Cancer Market Forecast 2020-2026, by Region, in Volume Table Bristol-Myers Squibb  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bristol-Myers Squibb  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Bristol-Myers Squibb  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table GlaxoSmithKline  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Menarini  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Menarini  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sanofi  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Ziopharm Oncology  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Ziopharm Oncology  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Alchemia  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Alchemia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Amgen  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Apotex  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Apotex  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table BioMarin Pharmaceutical  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of BioMarin Pharmaceutical  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table CellAct Pharma  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of CellAct Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cerulean Pharma  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Cerulean Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cipla  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Cipla  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cornerstone Pharmaceuticals  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Cornerstone Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Curis  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Curis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table CytRx  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of CytRx  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Eli Lilly  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Exelixis  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Exelixis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Fresenius Kabi  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Fresenius Kabi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Genentech  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Genentech  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Hikma Pharmaceuticals  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Hikma Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Hospira  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Hospira  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Intas Pharmaceuticals  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Intas Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Karyopharm Therapeutics  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Karyopharm Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Kyowa Hakko Kirin  Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Kyowa Hakko Kirin  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Ligand Pharmaceuticals Overview List Table Drugs for Non-small Cell Lung Cancer Business Operation of Ligand Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) List of Figure Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2019, by Type, in USD Million Figure Global Drugs for Non-small Cell Lung Cancer Market Growth 2016-2019, by Type, in Volume